Medtronic raises FY27 adjusted EPS guidance after upbeat Q1
Medtronic reported Q1 EPS of $1.45 and sales of $9.756B, beating consensus. It lifted FY27 adjusted EPS guidance to $5.94-$6 and raised organic revenue growth to 7.25%-7.75%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.